| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Apr 08, 2024 | Option Exercise | $17.90 | 4,075 | 72,942 | 63,012 | Apr 08, 2024, 05:22 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Apr 08, 2024 | Option Exercise | $17.90 | 733 | 13,121 | 47,803 | Apr 08, 2024, 05:21 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 08, 2024 | Option Exercise | $17.90 | 791 | 14,159 | 18,771 | Apr 08, 2024, 05:20 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Apr 08, 2024 | Option Exercise | $17.90 | 1,353 | 24,219 | 16,276 | Apr 08, 2024, 05:19 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Apr 08, 2024 | Option Exercise | $17.90 | 1,666 | 29,821 | 21,328 | Apr 08, 2024, 05:18 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Apr 08, 2024 | Option Exercise | $17.90 | 801 | 14,338 | 126,024 | Apr 08, 2024, 05:17 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 01, 2024 | Option Exercise | $19.70 | 514 | 10,126 | 16,868 | Apr 03, 2024, 05:25 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Apr 01, 2024 | Option Exercise | $19.70 | 521 | 10,264 | 124,099 | Apr 03, 2024, 05:23 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Apr 01, 2024 | Option Exercise | $19.70 | 1,903 | 37,489 | 57,095 | Apr 03, 2024, 05:22 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Apr 01, 2024 | Option Exercise | $19.70 | 1,084 | 21,355 | 19,062 | Apr 03, 2024, 05:21 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Apr 01, 2024 | Option Exercise | $19.70 | 880 | 17,336 | 15,152 | Apr 03, 2024, 05:20 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Apr 01, 2024 | Option Exercise | $19.70 | 477 | 9,397 | 46,039 | Apr 03, 2024, 05:18 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Mar 07, 2024 | Sale | $21.02 | 65,012 | 1,366,552 | 0 | Mar 11, 2024, 07:05 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Mar 04, 2024 | Sale | $21.49 | 12,742 | 273,834 | 73,930 | Mar 06, 2024, 05:37 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Mar 06, 2024 | Sale | $21.00 | 5,582 | 117,222 | 65,012 | Mar 06, 2024, 05:37 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Mar 01, 2024 | Option Exercise | $14.76 | 1,845 | 27,237 | 124,036 | Mar 05, 2024, 04:34 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 01, 2024 | Sale | $16.19 | 19,318 | 312,745 | 27,247 | Mar 01, 2024, 06:26 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Jan 15, 2024 | Option Exercise | $12.35 | 583 | 7,200 | 17,588 | Mar 01, 2024, 06:26 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Feb 28, 2024 | Option Exercise | $15.31 | 10,252 | 156,958 | 22,714 | Mar 01, 2024, 06:26 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Feb 27, 2024 | Sale | $11.45 | 20,312 | 232,471 | 55,048 | Feb 29, 2024, 04:26 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Jan 03, 2024 | Sale | $14.41 | 24,000 | 345,960 | 27,632 | Jan 04, 2024, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Dec 19, 2023 | Sale | $16.50 | 18,632 | 307,521 | 26,321 | Dec 21, 2023, 04:26 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Dec 07, 2023 | Sale | $9.75 | 57,200 | 557,954 | 73,492 | Dec 11, 2023, 04:20 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Oct 04, 2023 | Option Exercise | $16.01 | 52 | 833 | 17,005 | Oct 06, 2023, 04:26 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Jul 15, 2023 | Option Exercise | $12.35 | 581 | 7,175 | 13,558 | Sep 06, 2023, 07:08 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 1,155 | 20,513 | 16,336 | Sep 06, 2023, 07:08 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 228 | 4,049 | 16,882 | Sep 06, 2023, 07:08 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Jul 15, 2023 | Option Exercise | $12.35 | 292 | 3,606 | 12,845 | Sep 06, 2023, 07:07 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 1,353 | 24,029 | 13,969 | Sep 06, 2023, 07:07 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 543 | 9,644 | 14,420 | Sep 06, 2023, 07:07 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Sep 01, 2023 | Option Exercise | $17.76 | 4,432 | 78,712 | 48,134 | Sep 06, 2023, 07:06 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Sep 02, 2023 | Option Exercise | $17.76 | 2,187 | 38,841 | 52,516 | Sep 06, 2023, 07:06 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 791 | 14,048 | 14,318 | Sep 06, 2023, 07:06 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 547 | 9,715 | 15,632 | Sep 06, 2023, 07:06 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 801 | 14,226 | 121,993 | Sep 06, 2023, 07:04 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 577 | 10,248 | 123,380 | Sep 06, 2023, 07:04 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Sep 05, 2023 | Option Exercise | $9.70 | 800 | 7,756 | 45,292 | Sep 06, 2023, 07:03 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Sep 01, 2023 | Option Exercise | $17.76 | 734 | 13,036 | 43,674 | Sep 06, 2023, 07:03 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Sep 02, 2023 | Option Exercise | $17.76 | 507 | 9,004 | 44,892 | Sep 06, 2023, 07:03 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Jul 25, 2023 | Sale | $10.50 | 58,000 | 609,100 | 70,910 | Jul 27, 2023, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 26, 2023 | Option Exercise | $11.15 | 291 | 3,245 | 12,414 | Apr 28, 2023, 04:15 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 1,155 | 12,370 | 12,977 | Apr 11, 2023, 05:07 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 1,353 | 14,491 | 12,553 | Apr 11, 2023, 05:06 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 734 | 7,861 | 41,910 | Apr 11, 2023, 05:06 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Apr 10, 2023 | Option Exercise | $10.71 | 2,933 | 31,412 | 42,574 | Apr 11, 2023, 05:05 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 791 | 8,472 | 11,715 | Apr 11, 2023, 05:04 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Apr 10, 2023 | Option Exercise | $10.71 | 801 | 8,579 | 120,067 | Apr 11, 2023, 05:03 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 1,078 | 11,987 | 40,146 | Mar 20, 2023, 05:20 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 507 | 5,810 | 37,553 | Mar 20, 2023, 05:20 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Jan 15, 2023 | Option Exercise | $9.56 | 1,844 | 17,629 | 10,008 | Mar 20, 2023, 05:19 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 543 | 6,223 | 10,459 | Mar 20, 2023, 05:19 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 1,167 | 12,977 | 11,429 | Mar 20, 2023, 05:19 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 635 | 7,061 | 10,199 | Mar 20, 2023, 05:18 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Jan 15, 2023 | Option Exercise | $9.56 | 704 | 6,730 | 8,118 | Mar 20, 2023, 05:18 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 221 | 2,533 | 8,671 | Mar 20, 2023, 05:18 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Mar 16, 2023 | Option Exercise | $11.46 | 1,929 | 22,106 | 27,036 | Mar 20, 2023, 05:16 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Mar 20, 2023 | Option Exercise | $11.12 | 3,523 | 39,176 | 35,515 | Mar 20, 2023, 05:16 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 577 | 6,612 | 116,035 | Mar 20, 2023, 05:15 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 876 | 9,741 | 118,141 | Mar 20, 2023, 05:15 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Mar 16, 2023 | Option Exercise | $11.46 | 256 | 2,934 | 8,287 | Mar 20, 2023, 05:14 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Mar 20, 2023 | Option Exercise | $11.12 | 634 | 7,050 | 9,811 | Mar 20, 2023, 05:14 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Quart Barry D | Director | Nov 29, 2022 | Sale | $8.87 | 43,918 | 389,553 | 21,959 | Dec 01, 2022, 04:16 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Nov 07, 2022 | Sale | $8.52 | 56,714 | 483,203 | 64,692 | Nov 09, 2022, 04:16 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Oct 04, 2022 | Option Exercise | $14.23 | 52 | 740 | 7,414 | Oct 06, 2022, 04:18 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Jul 15, 2022 | Option Exercise | $9.56 | 360 | 3,442 | 7,732 | Sep 06, 2022, 04:12 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 563 | 6,441 | 8,164 | Sep 06, 2022, 04:12 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Sep 02, 2022 | Option Exercise | $11.44 | 1,929 | 22,068 | 22,396 | Sep 06, 2022, 04:11 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 507 | 5,800 | 36,335 | Sep 06, 2022, 04:10 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 547 | 6,258 | 7,671 | Sep 06, 2022, 04:10 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Jul 15, 2022 | Option Exercise | $9.56 | 1,048 | 10,019 | 113,261 | Sep 06, 2022, 04:09 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 577 | 6,601 | 114,648 | Sep 06, 2022, 04:09 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Jul 15, 2022 | Option Exercise | $9.56 | 703 | 6,721 | 6,744 | Sep 06, 2022, 04:08 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Sep 02, 2022 | Option Exercise | $11.44 | 228 | 2,608 | 7,291 | Sep 06, 2022, 04:08 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Apr 26, 2022 | Option Exercise | $9.99 | 282 | 2,817 | 6,357 | Apr 28, 2022, 04:31 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | CHAIRMAN & CEO | Mar 21, 2022 | Option Exercise | $10.98 | 5,446 | 59,797 | 17,756 | Mar 23, 2022, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | CHIEF COMMERCIAL OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,240 | 13,615 | 7,372 | Mar 23, 2022, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | CHIEF FINANCIAL OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,047 | 11,496 | 5,648 | Mar 23, 2022, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | CHIEF MEDICAL OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,686 | 18,512 | 35,117 | Mar 23, 2022, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | CHIEF ACCOUNTING OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,120 | 12,298 | 6,041 | Mar 23, 2022, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | CHIEF OPERATING OFFICER | Mar 21, 2022 | Option Exercise | $10.98 | 1,461 | 16,042 | 112,213 | Mar 23, 2022, 04:30 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | Chief Accounting Officer | Jun 30, 2020 | Option Exercise | $9.51 | 641 | 6,096 | 1,778 | Mar 18, 2022, 04:40 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | Chief Accounting Officer | Dec 31, 2020 | Option Exercise | $15.02 | 405 | 6,083 | 2,183 | Mar 18, 2022, 04:40 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | Chief Accounting Officer | Jul 15, 2021 | Option Exercise | $11.49 | 588 | 6,756 | 2,771 | Mar 18, 2022, 04:40 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | Chief Accounting Officer | Jan 15, 2022 | Option Exercise | $9.63 | 653 | 6,288 | 3,424 | Mar 18, 2022, 04:40 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Megna Michael R | Chief Accounting Officer | Mar 16, 2022 | Option Exercise | $10.13 | 269 | 2,725 | 3,930 | Mar 18, 2022, 04:40 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | Chief Commercial Officer | Jul 15, 2021 | Option Exercise | $11.49 | 963 | 11,065 | 4,345 | Mar 18, 2022, 04:39 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | Chief Commercial Officer | Jan 15, 2022 | Option Exercise | $9.63 | 1,546 | 14,888 | 5,891 | Mar 18, 2022, 04:39 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Moat Ross | Chief Commercial Officer | Mar 16, 2022 | Option Exercise | $10.13 | 544 | 5,511 | 6,342 | Mar 18, 2022, 04:39 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Paolini John F. | Chief Medical Officer | Mar 16, 2022 | Option Exercise | $10.13 | 598 | 6,058 | 31,127 | Mar 18, 2022, 04:39 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | Chairman & CEO | Mar 16, 2022 | Option Exercise | $10.13 | 1,922 | 19,470 | 4,647 | Mar 18, 2022, 04:38 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Ragosa Mark | Chief Financial Officer | Mar 16, 2022 | Option Exercise | $10.13 | 303 | 3,069 | 3,676 | Mar 18, 2022, 04:38 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | Chief Operating Officer | Jul 15, 2021 | Option Exercise | $11.49 | 868 | 9,973 | 106,810 | Mar 18, 2022, 04:36 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | Chief Operating Officer | Jan 15, 2022 | Option Exercise | $9.63 | 970 | 9,341 | 107,780 | Mar 18, 2022, 04:36 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Tessari Eben | Chief Operating Officer | Mar 16, 2022 | Option Exercise | $10.13 | 681 | 6,899 | 109,063 | Mar 18, 2022, 04:36 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | Chairman & CEO | Feb 10, 2021 | Sale | $23.07 | 1,137 | 26,231 | 83,336 | Feb 10, 2021, 07:07 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | Chairman & CEO | Feb 08, 2021 | Sale | $12.30 | 9,848 | 121,081 | 4,924 | Feb 10, 2021, 07:07 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | Chairman & CEO | Feb 08, 2021 | Sale | $23.00 | 4,528 | 104,144 | 108,042 | Feb 10, 2021, 07:07 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | Chairman & CEO | Feb 09, 2021 | Sale | $12.32 | 40,802 | 502,477 | 20,401 | Feb 10, 2021, 07:07 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | Chairman & CEO | Feb 09, 2021 | Sale | $23.08 | 23,569 | 543,973 | 84,473 | Feb 10, 2021, 07:07 PM | |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | Patel Sanj K | Chairman & CEO | Feb 10, 2021 | Sale | $12.32 | 3,200 | 39,440 | 1,600 | Feb 10, 2021, 07:07 PM |
Menu